BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 22188984)

  • 1. Human chorionic gonadotropin (hCG) prevents the transformed phenotypes induced by 17 beta-estradiol in human breast epithelial cells.
    Kocdor H; Kocdor MA; Russo J; Snider KE; Vanegas JE; Russo IH; Fernandez SV
    Cell Biol Int; 2009 Nov; 33(11):1135-43. PubMed ID: 19647089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel preclinical model of the normal human breast.
    Wilby AJ; Cabral S; Zoghi N; Howell SJ; Farnie G; Harrison H
    J Mammary Gland Biol Neoplasia; 2024 May; 29(1):9. PubMed ID: 38695983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: implications supporting the premise that hCG protects women against breast cancer.
    Lojun S; Bao S; Lei ZM; Rao CV
    Biol Reprod; 1997 Nov; 57(5):1202-10. PubMed ID: 9369188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Chorionic Gonadotropin-Mediated Induction of Breast Cancer Cell Proliferation and Differentiation.
    Dando I; Carmona-Carmona CA; Zampieri N
    Cells; 2021 Jan; 10(2):. PubMed ID: 33572731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Fertility Concerns on Tamoxifen Initiation and Persistence.
    Llarena NC; Estevez SL; Tucker SL; Jeruss JS
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26307641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian stimulation in patients with breast cancer.
    Muñoz E; González N; Muñoz L; Aguilar J; Velasco JA
    Ecancermedicalscience; 2015; 9():504. PubMed ID: 25729417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Malignant Pheochromocytoma Detected during Fertility Treatment.
    Hagiwara K; Hamano I; Kusaka A; Murasawa H; Tokui N; Imanishi K; Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Koie T; Ohyama C
    Case Rep Urol; 2014; 2014():646743. PubMed ID: 24653857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility preservation in breast cancer patients.
    Shien T; Nakatsuka M; Doihara H
    Breast Cancer; 2014 Nov; 21(6):651-5. PubMed ID: 23526260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology.
    Ezcurra D; Humaidan P
    Reprod Biol Endocrinol; 2014 Oct; 12():95. PubMed ID: 25280580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FSH replaced by low-dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniques.
    Martins WP; Vieira AD; Figueiredo JB; Nastri CO
    Cochrane Database Syst Rev; 2013 Mar; (3):CD010042. PubMed ID: 23543584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of infertility regimens on breast cancer cells: follicle-stimulating hormone and luteinizing hormone lack a direct effect on breast cell proliferation in vitro.
    Boukaidi SA; Cooley A; Hardy A; Matthews L; Zelivianski S; Jeruss JS
    Fertil Steril; 2012 Feb; 97(2):440-4. PubMed ID: 22188984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
    Agrawal R; Conway GS; Engmann L; Bekir JS; Jacobs HS
    Gynecol Endocrinol; 1998 Feb; 12(1):9-15. PubMed ID: 9526704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome.
    Filicori M; Cognigni GE; Taraborrelli S; Spettoli D; Ciampaglia W; de Fatis CT; Pocognoli P
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2659-63. PubMed ID: 10443656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovulatory follicle dysfunction in lactating dairy cows after treatment with Folltropin-V at the onset of luteolysis.
    Giordano JO; Edwards JL; Di Croce FA; Roper D; Rohrbach NR; Saxton AM; Schuenemann GM; Prado TM; Schrick FN
    Theriogenology; 2013 May; 79(8):1210-7. PubMed ID: 23534994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.